Literature DB >> 28251920

Nonpainful remote electrical stimulation alleviates episodic migraine pain.

David Yarnitsky1, Lana Volokh2, Alon Ironi2, Boaz Weller2, Merav Shor2, Alla Shifrin2, Yelena Granovsky2.   

Abstract

OBJECTIVE: To evaluate the efficacy of remote nonpainful electrical upper arm skin stimulation in reducing migraine attack pain.
METHODS: This is a prospective, double-blinded, randomized, crossover, sham-controlled trial. Migraineurs applied skin electrodes to the upper arm soon after attack onset for 20 minutes, at various pulse widths, and refrained from medications for 2 hours. Patients were asked to use the device for up to 20 attacks.
RESULTS: In 71 patients (299 treatments) with evaluable data, 50% pain reduction was obtained for 64% of participants based on best of 200-μs, 150-μs, and 100-μs pulse width stimuli per individual vs 26% for sham stimuli. Greater pain reduction was found for active stimulation vs placebo; for those starting at severe or moderate pain, reduction (1) to mild or no pain occurred in 58% (25/43) of participants (66/134 treatments) for the 200-μs stimulation protocol and 24% (4/17; 8/29 treatments) for placebo (p = 0.02), and (2) to no pain occurred in 30% (13/43) of participants (37/134 treatments) and 6% (1/17; 5/29 treatments), respectively (p = 0.004). Earlier application of the treatment, within 20 minutes of attack onset, yielded better results: 46.7% pain reduction as opposed to 24.9% reduction when started later (p = 0.02).
CONCLUSION: Nonpainful remote skin stimulation can significantly reduce migraine pain, especially when applied early in an attack. This is presumably by activating descending inhibition pathways via the conditioned pain modulation effect. This treatment may be proposed as an attractive nonpharmacologic, easy to use, adverse event free, and inexpensive tool to reduce migraine pain. CLINICALTRIALSGOV IDENTIFIER: NCT02453399. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for patients with an acute migraine headache, remote nonpainful electrical stimulation on the upper arm skin reduces migraine pain.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Year:  2017        PMID: 28251920     DOI: 10.1212/WNL.0000000000003760

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study.

Authors:  Jennifer S Gewandter; Jenna Chaudari; Chinazom Ibegbu; Rachel Kitt; Jennifer Serventi; Joy Burke; Eva Culakova; Noah Kolb; Kathleen A Sluka; Mohamedtaki A Tejani; Nimish A Mohile
Journal:  Support Care Cancer       Date:  2018-08-27       Impact factor: 3.603

Review 2.  Neurostimulation methods in the treatment of chronic pain.

Authors:  X Moisset; M Lanteri-Minet; D Fontaine
Journal:  J Neural Transm (Vienna)       Date:  2019-10-21       Impact factor: 3.575

Review 3.  Noninvasive Neuromodulation in Migraine.

Authors:  Benzion Blech; Amaal J Starling
Journal:  Curr Pain Headache Rep       Date:  2020-12-16

Review 4.  A Short Review of the Non-invasive Transcutaneous Pericranial Electrical Stimulation Techniques and their Application in Headache.

Authors:  Licia Grazzi; Emanuela Sansone; Paul Rizzoli
Journal:  Curr Pain Headache Rep       Date:  2018-01-19

Review 5.  Devices for Episodic Migraine: Past, Present, and Future.

Authors:  David Moreno-Ajona; Jan Hoffmann; Simon Akerman
Journal:  Curr Pain Headache Rep       Date:  2022-02-11

Review 6.  Outpatient Approach to Resistant and Refractory Migraine in Children and Adolescents: a Narrative Review.

Authors:  Alison Marshall; Rebecca Lindsay; Michelle A Clementi; Amy A Gelfand; Serena L Orr
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-26       Impact factor: 6.030

Review 7.  Characterising the Features of 381 Clinical Studies Evaluating Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Relief: A Secondary Analysis of the Meta-TENS Study to Improve Future Research.

Authors:  Mark I Johnson; Carole A Paley; Priscilla G Wittkopf; Matthew R Mulvey; Gareth Jones
Journal:  Medicina (Kaunas)       Date:  2022-06-14       Impact factor: 2.948

Review 8.  Emerging Treatments in Episodic Migraine.

Authors:  Kate W Grimsrud; Rashmi B Halker Singh
Journal:  Curr Pain Headache Rep       Date:  2018-07-16

Review 9.  Non-invasive neuromodulation in the acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Oliver Clark; Areej Mahjoub; Nily Osman; Ann-Marie Surmava; Saber Jan; Ana Marissa Lagman-Bartolome
Journal:  Neurol Sci       Date:  2021-10-26       Impact factor: 3.307

10.  Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.

Authors:  Juliana H VanderPluym; Rashmi B Halker Singh; Meritxell Urtecho; Allison S Morrow; Tarek Nayfeh; Victor D Torres Roldan; Magdoleen H Farah; Bashar Hasan; Samer Saadi; Sahrish Shah; Rami Abd-Rabu; Lubna Daraz; Larry J Prokop; Mohammad Hassan Murad; Zhen Wang
Journal:  JAMA       Date:  2021-06-15       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.